RxDoctor Payments Data

Sandesh Rao, MD

Orthopaedic Surgery · Washington, DCNPI 1265708093

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (52.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 76.6% of it on its own, with 11 other manufacturers making up the rest.

$21,177in general payments, 2019–2025

Across 62 payments — averaging $341.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$16K
  • Zimmer Biomet$2K
  • Supreme Orthopedic Systems, LLC$1K
  • Orthalign Inc$612
  • Stryker$516
  • Medtronic$263
  • plus $509 from 6 others

What the payments were for

  • Travel & lodging$5,27725%
  • Food & beverage$4,70022%
  • Education$11,20053%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,177 in reported general payments places this provider in the 80th percentile of 46 orthopaedic surgery providers in District of Columbia.

See all orthopaedic surgery providers in District of Columbia

Medicare billing

Part B allowed, 2024
$477,148
Medicare patients
1,063
Services billed
3,960

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cefadroxil82$1,986
Methylprednisolone93$840
Meloxicam112$574
Celecoxib13$173
Cyclobenzaprine Hcl17$89
Tramadol Hcl17$68

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →